Animal health company Elanco (NYSE:ELAN) reported Q1 CY2025 results , but sales were flat year on year at $1.19 billion. The ...

Obesity drugmaker Novo Nordisk has today downgraded its 2025 sales forecast, ending a four-year stretch of steady guidance ...

AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it ...